Brief: ExpreS2ion Announces SEK 6.7 Mln Grant For Development Influenza Vaccine
31/03/2020 08:04
March 31 (Reuters) - ExpreS2ion Biotech Holding AB
EXPRS2.ST :
* EXPRES2ION ANNOUNCES 6.7 MSEK EU HORIZON 2020 GRANT FOR
THE
DEVELOPMENT OF A UNIQUE INFLUENZA VACCINE
* GRANT, IS ESTIMATED TO BE RECOGNISED AS REVENUE EVENLY
FROM H2
2020 THROUGH H2 2021
Source text for Eikon: ID:nWkr7HYYjz
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations